Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.
about
Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanesRegional but fatal: Intraperitoneal metastasis in gastric cancerTumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility studyColonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathwayEstablishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer.Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan.Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites.Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.Improvement of anti-cancer drug efficacy via thermosensitive hydrogel in peritoneal carcinomatosis in gastric cancer.Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.Treatment of patients with peritoneal metastases from gastric cancer.Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategyLow-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil
P2860
Q26776201-A9695B58-A6B7-4FF0-B9F7-C4621D27ACE3Q28067269-1DF75827-3D7E-4DAC-84D6-E00DAE557982Q30372640-BC10AB88-425B-4392-A88B-D14FABB4289BQ33418948-C525F074-0702-49F3-995E-B1269C760FCBQ33728822-13E8743F-A958-4C40-B361-602F250E1ACAQ35012479-1615377F-608E-4F0E-9270-B321652A6E2FQ36240916-98F0BB9D-9A02-4DE9-B276-022A15491056Q38183786-BC41D3AB-0C2E-431C-ACFB-1E66142C50A1Q38800565-03B2365A-29D5-430E-85AF-91741CBC81E5Q38986946-273C89E8-4CED-4F43-93C1-04D1F812342CQ39096119-E736682E-7A42-49B8-8F37-89F776D00628Q39151711-EE7E47C0-9538-45ED-9EBF-42D69B08E24DQ47101405-3FC62927-FDB0-4317-8437-035152126FB5Q49171796-719851E8-1C76-43A8-A900-AF3708241D66Q50525152-CFF0902B-4068-404F-AE0E-AE2A56FB3C7AQ55318427-A2A2B8B3-FE74-4F6F-A3B0-DDA1F3CB9F78Q57070174-353F20A8-FE4E-45C0-91DE-FB417EB7EFC9Q58777726-A8B0C929-CAB3-4C70-8A80-A663417AF8CE
P2860
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Phase I/II study of intraperit ...... ith peritoneal carcinomatosis.
@ast
Phase I/II study of intraperit ...... ith peritoneal carcinomatosis.
@en
type
label
Phase I/II study of intraperit ...... ith peritoneal carcinomatosis.
@ast
Phase I/II study of intraperit ...... ith peritoneal carcinomatosis.
@en
prefLabel
Phase I/II study of intraperit ...... ith peritoneal carcinomatosis.
@ast
Phase I/II study of intraperit ...... ith peritoneal carcinomatosis.
@en
P2093
P2860
P1476
Phase I/II study of intraperit ...... ith peritoneal carcinomatosis.
@en
P2093
J Kinoshita
Society for Study of Peritoneal Carcinomatosis in Gastric Cancer
T Fujimura
Y Watanabe
P2860
P2888
P304
P356
10.1007/S00280-013-2122-0
P577
2013-02-20T00:00:00Z